Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Avelas Biosciences, Inc.

By efain on Tue, 12/15/2020 - 14:26
  • Read more about Avelas Biosciences, Inc.

Cook MyoSite, Incorporated

By efain on Mon, 12/07/2020 - 17:00
  • Read more about Cook MyoSite, Incorporated
Expanded Access Listings

Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)

This is an expanded access program (EAP) for eligible participants designed to provideaccess to autologous muscle derived cells (AMDCs). Treating physicians may submitrequests for expanded access to Cook MyoSite's investigational product by email toMYO-ExpandedAccess@CookMyoSite.com.

Oscillation and Lung Expansion Therapy in Patients With COVID-19

  • Read more about Oscillation and Lung Expansion Therapy in Patients With COVID-19

Patients Reactions Towards Their Diagnosis as Having COVID-19

  • Read more about Patients Reactions Towards Their Diagnosis as Having COVID-19

Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

  • Read more about Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

Inflammatory Signal Inhibitors for COVID-19 (MATIS)

  • Read more about Inflammatory Signal Inhibitors for COVID-19 (MATIS)

SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)

  • Read more about SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)

An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection

  • Read more about An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection

Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

  • Read more about Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

The Salivary Raman COVID-19 Fingerprint

  • Read more about The Salivary Raman COVID-19 Fingerprint

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 234
  • Page 235
  • Page 236
  • Page 237
  • Current page 238
  • Page 239
  • Page 240
  • Page 241
  • Page 242
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA